Project Grant R01DK140676
Award Date
7/18/24
Completion Date
4/30/27
Dollars Obligated
$1M
Federal Grant Program
93.847
Assistance Type
Project Grant
Place of Performance
West Hollywood, CA 90048, USA
Similar Awards
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $316,102 to Mayo Clinic to conduct a pilot, randomized, double-blind, placebo-controlled clinical trial. The trial aims to evaluate the efficacy and safety of proteolytic activity-guided fecal microbiota transplantation (FMT) for improving symptoms in patients with...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $196,940 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to conduct a 5-year study on a positive psychology intervention for irritable bowel syndrome (IBS). The project aims to examine the feasibility, acceptability, and preliminary efficacy of a 9-week phone-based positive...
This Project Grant award from the National Center for Complementary and Integrative Health (NCCIH), under the Research and Training in Complementary and Integrative Health program (CFDA 93.213), provides $254,892 to Ralphvr Inc. to develop a virtual reality (VR) application called "Virtual Partner" to reduce delirium in intensive care unit (ICU) patients. The key objectives of the award are to: 1) obtain feedback from ICU staff and former ICU patients to inform the VR application...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), totals $352,125 and is focused on evaluating heart rate variability (HRV) as a biomarker for clinical symptoms and psychological functioning in pediatric patients with inflammatory bowel disease (IBD). The award will support a study to: 1) determine the relationship between baseline HRV...
This Project Grant award from the National Center for Complementary and Integrative Health (NCCIH), under the Research and Training in Complementary and Integrative Health federal grant program (CFDA 93.213), provides $762,489 to Yale University to evaluate the feasibility, acceptability, adherence, safety, and potential implementation barriers of a home-based transcutaneous auricular vagus nerve stimulation (TAVNS) intervention for pain and symptom management among young adults (18-29 years...
The University of Connecticut received a $1,941,591 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research) to develop an objective integrated multimodal electrophysiological (OIME) index that quantifies the level of visceral pain in patients with irritable bowel syndrome (IBS). The key products/services to be delivered under this 5-year award include: Establishing the OIME index...
This Project Grant award of $117,000 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) is funding research to delineate the role of substance P-mediated activation of mast cells in irritable bowel syndrome (IBS) pathophysiology. The key objectives are to determine the mechanisms of substance P-induced colonic mast cell activation and elucidate the contributions of mast...
The National Cancer Institute (NCI), under the federal Cancer Treatment Research program (CFDA 93.395), awarded a $403,383 Project Grant to the Medstar Health Research Institute Inc. to develop and pilot test a cognitive behavioral theory-assisted virtual reality (VR) prototype for chronic cancer pain management. The collaborative project between Duke University and Medstar Health aims to iteratively design and evaluate the VR-CAN prototype, which integrates evidence-based strategies to...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) totaling $857,958 will support research to assess autonomic nervous system (ANS) regulation and its link to gastrointestinal disorders in children. The primary awardee, The Medical College of Wisconsin, Inc., will develop an ANS-sensing system to measure vagal efficiency and evaluate the efficacy of personalized...
This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 - Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $604,082 to Duke University to assess the use of psyllium, a soluble fiber, in mitigating fructan-induced gastrointestinal symptoms in children with irritable bowel syndrome (IBS). The key objectives are to: 1) investigate the effect of psyllium at two different doses on microbial fructan fermentation when...